Molecular profiling to diagnose a case of atypical dermatomyositis

Journal of Investigative Dermatology

Volumn 133, Issue 12, 2013, Pages 2796-2799

  Sarin, Kavita Y ^a   Chung, Lorinda ^b   Kim, Jinah ^a   Higgs, Brandon W ^c   Jallal, Bahia ^c   Yao, Yihong ^c   Fiorentino, David F ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^c MEDIMMUNE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AUTOIMMUNE DISEASE; CASE REPORT; DERMATOMYOSITIS; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LETTER; MOLECULAR GENETICS; PRIORITY JOURNAL; PSORIASIS; SKIN BIOPSY;

EID: 84887824672     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2013.240     Document Type: Letter

References (15)

1. Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292:344-7
2. Caproni M, Torchia D, Cardinali C et al. (2004) Infiltrating cells, related cytokines and chemokine receptors in lesional skin of patients with dermatomyositis. Br J Dermatol 151:784-91
3. Chaussabel D, Quinn C, Shen J et al. (2008) A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus. Immunity 29:150-64
4. de Jongh GJ, Zeeuwen PL, Kucharekova M et al. (2005) High expression levels of keratinocyte antimicrobial proteins in psoriasis compared with atopic dermatitis. J Invest Dermatol 125:1163-73
5. Golub TR, Slonim DK, Tamayo P et al. (1999) Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286: 531-7
6. Greenberg SA, Pinkus JL, Pinkus GS et al. (2005) Interferon-alpha/beta- mediated innate immune mechanisms in dermatomyositis. Ann Neurol 57:664-78
7. Gudjonsson JE, Ding J, Li X et al. (2009) Global gene expression analysis reveals evidence for decreased lipid biosynthesis and increased innate immunity in uninvolved psoriatic skin. J Invest Dermatol 129:2795-804
8. Ito A, Funasaka Y, Shimoura A et al. (1995) Dermatomyositis associated with diffuse dermal neutrophilia. Int J Dermatol 34:797-8
9. Lew W, Bowcock AM, Krueger JG (2004) Psoriasis vulgaris: cutaneous lymphoid tissue supports T-cell activation and Type 1 inflammatory gene expression. Trends Immunol 25: 295-305
10. Pietrzak A, Michalak-Stoma A, Chodorowska G et al. (2010) Lipid disturbances in psoriasis: an update. Mediators Inflamm. e-pub ahead of print 20 July 2010
11. Scott JP, Arroyave C (1987) Activation of complement and coagulation in juvenile dermatomyositis. Arthritis Rheum 30:572-6
12. Sontheimer RD (2002) Dermatomyositis: an overview of recent progress with emphasis on dermatologic aspects. Dermatol Clin 20:387-408
13. Van de Kerkhof PC, Van Erp PE (1996) The role of epidermal proliferation in the pathogenesis of psoriasis. Skin Pharmacol 9:343-54
14. Wenzel J, Schmidt R, Proelss J et al. (2006) Type I interferon-associated skin recruitment of CXCR3 lymphocytes in dermatomyositis. Clin Exp Dermatol 31:576-82
15. Yao Y, Richman L, Morehouse C et al. (2008) Type I interferon: potential therapeutic target for psoriasis PLoS One 3:e2737